Twist Bioscience Director Sold 12,000 Shares. Here's What That Means for Investors.
This synthetic DNA specialist, leveraging silicon chip technology, reported a notable insider sale amid a year of strong share gains.
Twist Bioscience Director Sold 12,000 Shares. Here's What That Means for Investors.
Overview
Jan Johannessen, Director at Twist Bioscience Corporation (NASDAQ:TWST), reported the exercise and immediate sale of 12,000 shares of Common Stock for a transaction value of approximately $673,000 according to the SEC Form 4 filing.
Transaction value based on SEC Form 4 weighted average purchase price ($56.12); post-transaction value based on May 12, 2026 market close ($993,336.30).
Details
* 1-year price change calculated using May 12th, 2026 as the reference date.
Source
Originally published at www.fool.com.
Related Articles
- Adobe’s CFO is departing for Marvell. And it’s one more reason for investors to choose chips over software.
- There’s a 68% chance the stock market ends the year higher. Why the headlines shouldn’t disrupt your portfolio.
- Claiming Social Security Early Is Costly for Everyone, but These Seniors Pay the Biggest Price
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.
